In pulmonary fibrosis, downregulation of NRF2 not only increases OS but also releases inhibition on PI3K/AKT signaling, accompanied by proliferation of lung fibroblasts (LFs) and excessive collagen secretion (Liu P. et al., 2021; Liu et al., 2013). Here, PIK3CB is linked to pulmonary fibrosis.